25 July 2021

Safety alerts

Reference: CIR-2021-00000123

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated

 

• Significant safety issue for EVRA (norelgestromin/ethinylestradiol)
• Medical Device Recall Lyra SARS-CoV-2 Assay (M120)

 

Thanks in advance for your good co-operation

Drug Control Sect

Health Regulation Sector

DHA

 

 

Supporting Documents:

EVRA (norelgestromin-ethinylestradiol) تحذير.pdf:

View Document

Lyra SARS-CoV-2 Assay (M120) تقارير سلامة لوسيلة طبية (002)-1.pdf:

View Document